Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.
Also called NCT01761656
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT01761656
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01761656. Randomized; no masking; primary purpose prevention. Start 2012-12 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
- Acronym
- ARMYDA-IMR
- Condition
- Stable Angina
- Condition
- Unstable Angina
- Condition
- Acute Non-ST-segment Elevation Myocardial Infarction
- Intervention (Drug)
- loading dose atorvastatin
- Intervention (Drug)
- conventional dose atorvastatin
- Lead sponsor
- Central South University
Record details
- Record id
cardio:ct-nct01761656- Content hash
5998cf26f59c185a4b1c64e4c92cba7d25edfd653dc02efde07baaf2bf6b52fd